Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer
Research article (Peer reviewed)
Kiran Kumar Jagarlamudi
Department of Anatomy, Physiology and Biochemistry
Faculty of Veterinary Medicine and Animal Sciences
Email: kirankumar.j@slu.se
ORCID: 0000-0003-1567-5863
Publications
2022
Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies
Research article (Peer reviewed)
2019
The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate-specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditions
Research article (Peer reviewed)
2018
Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development
Research article (Peer reviewed)
Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker
Review article (Peer reviewed)
2016
A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
Research article (Peer reviewed)
2015
Diagnostic implications of the molecular forms and levels of serum thymidine kinase 1 in different canine malignancies
Doctoral thesis
A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management
Research article (Peer reviewed)
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
Research article (Peer reviewed)
2014
The new TK 201 ELISA provides prognostic information in patients with breast cancer
Conference abstract